Cargando…

Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements

AIM: Our aim was to investigate the association among elastographic parameters of liver steatosis and fibrosis, controlled attenuation parameter (CAP) and liver stiffness measurement (LSM), with gastroesophageal reflux disease (GERD). METHODS: In this prospective, cross-sectional study, we have eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikolasevic, Ivana, Poropat, Goran, Filipec Kanizaj, Tajana, Skenderevic, Nadija, Zelic, Marko, Matasin, Marija, Vranic, Luka, Kresovic, Andrea, Hauser, Goran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925017/
https://www.ncbi.nlm.nih.gov/pubmed/33688490
http://dx.doi.org/10.1155/2021/6670065
_version_ 1783659204610883584
author Mikolasevic, Ivana
Poropat, Goran
Filipec Kanizaj, Tajana
Skenderevic, Nadija
Zelic, Marko
Matasin, Marija
Vranic, Luka
Kresovic, Andrea
Hauser, Goran
author_facet Mikolasevic, Ivana
Poropat, Goran
Filipec Kanizaj, Tajana
Skenderevic, Nadija
Zelic, Marko
Matasin, Marija
Vranic, Luka
Kresovic, Andrea
Hauser, Goran
author_sort Mikolasevic, Ivana
collection PubMed
description AIM: Our aim was to investigate the association among elastographic parameters of liver steatosis and fibrosis, controlled attenuation parameter (CAP) and liver stiffness measurement (LSM), with gastroesophageal reflux disease (GERD). METHODS: In this prospective, cross-sectional study, we have evaluated 937 patients with one or more components of the metabolic syndrome who had an esophagogastroduodenoscopy (EGD) due to GERD symptoms. In all patients, a laboratory analysis, an abdominal ultrasound, and FibroScan measurements were done. GERD was defined by EGD. RESULTS: The mean body mass index (BMI) of the study population was 30.95 ± 5.45 kg/m(2). The prevalence of increased CAP was 82.6% (774/937). Patients with increased CAP were younger, were more obese, had higher prevalence of hypertension, diabetes, and dyslipidemia, and had higher values of aminotransferases. Similar results of higher prevalence in patients with elevated CAP were observed with GERD, hiatal hernia, and insufficient cardia (defined as deficient or absent closure of the gastric inlet in relation to the esophagus). Additionally, patients with elevated CAP had a higher prevalence of GERD grades B and C in comparison to those without elevated CAP. Consequently, patients who did not have elevated CAP had a higher prevalence of GERD grade A. Even though we have found an upward trend in the prevalence of GERD, hiatal hernia, and insufficient cardia, there was no significant difference between subjects with fibrosis (F) 1-2 and F3-4 stage of fibrosis or F1 and F2-4. In a binary logistic regression, a significant positive association with GERD was obtained for CAP. Furthermore, a significant positive association with hiatal hernia was obtained for BMI and CAP. Finally, a significant positive association with hiatal hernia was obtained with CAP in multivariate analysis. CONCLUSION: To the best of our knowledge, our study is the first to reveal a positive association between CAP as a surrogate marker of liver steatosis and GERD after adjustments for other clinical variables.
format Online
Article
Text
id pubmed-7925017
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-79250172021-03-08 Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements Mikolasevic, Ivana Poropat, Goran Filipec Kanizaj, Tajana Skenderevic, Nadija Zelic, Marko Matasin, Marija Vranic, Luka Kresovic, Andrea Hauser, Goran Can J Gastroenterol Hepatol Research Article AIM: Our aim was to investigate the association among elastographic parameters of liver steatosis and fibrosis, controlled attenuation parameter (CAP) and liver stiffness measurement (LSM), with gastroesophageal reflux disease (GERD). METHODS: In this prospective, cross-sectional study, we have evaluated 937 patients with one or more components of the metabolic syndrome who had an esophagogastroduodenoscopy (EGD) due to GERD symptoms. In all patients, a laboratory analysis, an abdominal ultrasound, and FibroScan measurements were done. GERD was defined by EGD. RESULTS: The mean body mass index (BMI) of the study population was 30.95 ± 5.45 kg/m(2). The prevalence of increased CAP was 82.6% (774/937). Patients with increased CAP were younger, were more obese, had higher prevalence of hypertension, diabetes, and dyslipidemia, and had higher values of aminotransferases. Similar results of higher prevalence in patients with elevated CAP were observed with GERD, hiatal hernia, and insufficient cardia (defined as deficient or absent closure of the gastric inlet in relation to the esophagus). Additionally, patients with elevated CAP had a higher prevalence of GERD grades B and C in comparison to those without elevated CAP. Consequently, patients who did not have elevated CAP had a higher prevalence of GERD grade A. Even though we have found an upward trend in the prevalence of GERD, hiatal hernia, and insufficient cardia, there was no significant difference between subjects with fibrosis (F) 1-2 and F3-4 stage of fibrosis or F1 and F2-4. In a binary logistic regression, a significant positive association with GERD was obtained for CAP. Furthermore, a significant positive association with hiatal hernia was obtained for BMI and CAP. Finally, a significant positive association with hiatal hernia was obtained with CAP in multivariate analysis. CONCLUSION: To the best of our knowledge, our study is the first to reveal a positive association between CAP as a surrogate marker of liver steatosis and GERD after adjustments for other clinical variables. Hindawi 2021-02-23 /pmc/articles/PMC7925017/ /pubmed/33688490 http://dx.doi.org/10.1155/2021/6670065 Text en Copyright © 2021 Ivana Mikolasevic et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Mikolasevic, Ivana
Poropat, Goran
Filipec Kanizaj, Tajana
Skenderevic, Nadija
Zelic, Marko
Matasin, Marija
Vranic, Luka
Kresovic, Andrea
Hauser, Goran
Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements
title Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements
title_full Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements
title_fullStr Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements
title_full_unstemmed Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements
title_short Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements
title_sort association between gastroesophageal reflux disease and elastographic parameters of liver steatosis and fibrosis: controlled attenuation parameter and liver stiffness measurements
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925017/
https://www.ncbi.nlm.nih.gov/pubmed/33688490
http://dx.doi.org/10.1155/2021/6670065
work_keys_str_mv AT mikolasevicivana associationbetweengastroesophagealrefluxdiseaseandelastographicparametersofliversteatosisandfibrosiscontrolledattenuationparameterandliverstiffnessmeasurements
AT poropatgoran associationbetweengastroesophagealrefluxdiseaseandelastographicparametersofliversteatosisandfibrosiscontrolledattenuationparameterandliverstiffnessmeasurements
AT filipeckanizajtajana associationbetweengastroesophagealrefluxdiseaseandelastographicparametersofliversteatosisandfibrosiscontrolledattenuationparameterandliverstiffnessmeasurements
AT skenderevicnadija associationbetweengastroesophagealrefluxdiseaseandelastographicparametersofliversteatosisandfibrosiscontrolledattenuationparameterandliverstiffnessmeasurements
AT zelicmarko associationbetweengastroesophagealrefluxdiseaseandelastographicparametersofliversteatosisandfibrosiscontrolledattenuationparameterandliverstiffnessmeasurements
AT matasinmarija associationbetweengastroesophagealrefluxdiseaseandelastographicparametersofliversteatosisandfibrosiscontrolledattenuationparameterandliverstiffnessmeasurements
AT vranicluka associationbetweengastroesophagealrefluxdiseaseandelastographicparametersofliversteatosisandfibrosiscontrolledattenuationparameterandliverstiffnessmeasurements
AT kresovicandrea associationbetweengastroesophagealrefluxdiseaseandelastographicparametersofliversteatosisandfibrosiscontrolledattenuationparameterandliverstiffnessmeasurements
AT hausergoran associationbetweengastroesophagealrefluxdiseaseandelastographicparametersofliversteatosisandfibrosiscontrolledattenuationparameterandliverstiffnessmeasurements